Clinical trial
Homocystinuria: Treatment With N-Acetylcysteine
NCT00483314 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Completed
Key facts
| NCT number | NCT00483314 |
|---|---|
| Title | Homocystinuria: Treatment With N-Acetylcysteine |
| Official title | Homocystinuria: Treatment With N-Acetylcysteine |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Collaborators | March of Dimes |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Homocystinuria |
| Intervention type | Drug |
| Interventions | N-acetylcysteine |
| Enrollment | 5 |
| Start date | Nov 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Jun 7, 2007 |
| Last update posted | Feb 18, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: